| | Class 2 Device Recall |  |
| Date Initiated by Firm | February 21, 2003 |
| Date Posted | April 01, 2003 |
| Recall Status1 |
Terminated 3 on September 08, 2003 |
| Recall Number | Z-0702-03 |
| Recall Event ID |
25629 |
| PMA Number | P000009/S4 |
| Product Classification |
Implantable Cardioverter Defibrillator (Non-Crt) - Product Code LWS
|
| Product | Tachos DR - Atrial TX Implantable Cardioverter Defibrillators |
| Code Information |
Model No. 122 499 Serial Nos. 78010961, 78012035, 78012076, 78012077, 78012083, 78012090-78012092, 78012103-78012105, 78012109-78012111, 78012117-78012120, 78012122-78012125,78012127, 78012132, 78012163, 78012197, 78012236, 78012292, 78012296, 78012298-78012302, 78012352, 78012354, 78012355, 78012366, 78012369, 78012374, 78012386, 78012413, 78012415, 78012564, 78012652 |
Recalling Firm/ Manufacturer |
Biotronik Inc 6024 Jean Road Lake Oswego OR 97035-5369
|
| For Additional Information Contact | Jon Brumbaugh 888-345-0374 |
Manufacturer Reason for Recall | Potential for battery to delivery less than full amount of energy |
FDA Determined Cause 2 | Other |
| Action | The firm issued an 'URGENT - VOLUNTARY MEDICAL DEVICE' recall letter dated 2/21/03 to the physicians. This letter explains the issue and recommends scheduling an immediate follow-up with the patients.
The letter describes conditions under which the patient should be monitored on a weekly basis (versus every 3 months), and under which conditions the device should be explanted. |
| Quantity in Commerce | 49 devices (45 still implanted) |
| Distribution | The firm distributed devices to doctors located throughout the U.S.
There is no international distribution from this firm.
|
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|